Pelican Therapeutics

About:

Pelican Therapeutics develops biologic agents that represent the next generation of TNF based immunotherapy.

Website: http://www.pelicantherapeutics.com/

Top Investors: Cancer Prevention and Research Institute of Texas

Description:

Pelican Therapeutics develops biologic agents that represent the next generation of TNF based immunotherapy. It operates as a biotechnology company that focuses on the development and commercialization of monoclonal antibody and fusion protein-based therapies that are designed to activate the immune system. It was incorporated in 2009 and is based in Boca Raton, Florida.

Total Funding Amount:

$15.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boca Raton, Florida, United States

Founded Date:

2009-01-01

Contact Email:

josiah(AT)pelicantherapeutics.com

Founders:

Taylor Schreiber

Number of Employees:

1-10

Last Funding Date:

2016-05-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai